Budget impact model for determining the costs of introducing inhaled salmeterol/fluticasone propionate combination for the management of persistent asthma in France
Year of publication: |
2002
|
---|---|
Authors: | Detournay, B. ; Pribil, C. ; Jourdanne, C. ; Price, M. |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 3.2002, 3, p. 149-155
|
Publisher: |
Springer |
Subject: | Keywords Budget impact model | Salmeterol/fluticasone propionate | Asthma | France |
-
Markham, Anthony, (2000)
-
Development of an Economic Model to Assess the Cost Effectiveness of Asthma Management Strategies
Price, Martin J., (2002)
-
Sheth, Ketan, (2002)
- More ...
-
Costs and management of patients with hemophilia A in France : the Hemraude study
Laurendeau, C., (2022)
-
A Markov model of treatment of newly diagnosed epilepsy in the UK
Remák, E., (2003)
-
Monitoring, reputation, and greenbeard reciprocity in a Shuar work team
Price, M., (2006)
- More ...